Title : Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC).

Pub. Date : 2019 Nov

PMID : 31839159






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination of atezolizumab with nab-paclitaxel in a phase III study has recently seen success in terms of improved progression free and overall survival for the PD-L1 -positive population of metastatic TNBC in the first line/newly relapsed setting [3]. nab CD274 molecule Homo sapiens